Environmental tobacco smoke exposure and ischaemic heart disease: an evaluation of the evidence

被引:382
作者
Law, MR [1 ]
Morris, JK [1 ]
Wald, NJ [1 ]
机构
[1] ROYAL LONDON SCH MED, LONDON EC1M 6BQ, ENGLAND
来源
BMJ-BRITISH MEDICAL JOURNAL | 1997年 / 315卷 / 7114期
关键词
D O I
10.1136/bmj.315.7114.973
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives: To estimate the risk of ischaemic heart disease caused by exposure to environmental tobacco smoke and to explain why the associated excess risk is almost half that of smoking 20 cigarettes per day when the exposure is only about 1% that of smoking. Design: Meta-analysis of all 19 acceptable published studies of risk of ischaemic heart disease in lifelong non-smokers who live with a smoker and in those who live with a non-smoker, five large prospective studies of smoking and ischaemic heart disease, and studies of platelet aggregation and studies of diet according to exposure to tobacco smoke. Results: The relative risk of ischaemic heart disease associated with exposure to environmental tobacco smoke was 1.30 (95% confidence interval 1.22 to 1.38) at age 65. At the same age the estimated relative risk associated with smoking one cigarette per day was similar (1.39 (1.18 to 1.64)), while for 20 per day it was 1.78 (1.31 to 2.44). Two separate analyses indicated that non-smokers who live with smokers eat a diet that places them at a 6% higher risk of ischaemic heart disease, so the direct effect of environmental tobacco smoke is to increase risk by 23% (14% to 33%), since 1.30/1.06 = 1.23. Platelet aggregation provides a plausible and quantitatively consistent mechanism for the low dose effect. The increase in platelet aggregation produced experimentally by exposure to environmental tobacco smoke would be expected to have acute effects increasing the risk of ischaemic heart disease by 34%. Conclusion: Breathing other people's smoke is an important and avoidable cause of ischaemic heart disease, increasing a person's risk by a quarter.
引用
收藏
页码:973 / 980
页数:8
相关论文
共 93 条
[1]   COLLABORATIVE OVERVIEW OF RANDOMIZED TRIALS OF ANTIPLATELET THERAPY .1. PREVENTION OF DEATH, MYOCARDIAL-INFARCTION, AND STROKE BY PROLONGED ANTIPLATELET THERAPY IN VARIOUS CATEGORIES OF PATIENTS [J].
ALTMAN, R ;
CARRERAS, L ;
DIAZ, R ;
FIGUEROA, E ;
PAOLASSO, E ;
PARODI, JC ;
CADE, JF ;
DONNAN, G ;
EADIE, MJ ;
GAVAGHAN, TP ;
OSULLIVAN, EF ;
PARKIN, D ;
RENNY, JTG ;
SILAGY, C ;
VINAZZER, H ;
ZEKERT, F ;
ADRIAENSEN, H ;
BERTRANDHARDY, JM ;
BRAN, M ;
DAVID, JL ;
DRICOT, J ;
LAVENNEPARDONGE, E ;
LIMET, R ;
LOWENTHAL, A ;
MORIAU, M ;
SCHAPIRA, S ;
SMETS, P ;
SYMOENS, J ;
VERHAEGHE, R ;
VERSTRAETE, M ;
ATALLAH, A ;
BARNETT, H ;
BATISTA, R ;
BLAKELY, J ;
CAIRNS, JA ;
COTE, R ;
CROUCH, J ;
EVANS, G ;
FINDLAY, JM ;
GENT, M ;
LANGLOIS, Y ;
LECLERC, J ;
NORRIS, J ;
PINEO, GF ;
POWERS, PJ ;
ROBERTS, R ;
SCHWARTZ, L ;
SICURELLA, J ;
TAYLOR, W ;
THEROUX, P .
BMJ-BRITISH MEDICAL JOURNAL, 1994, 308 (6921) :81-100
[2]   ACUTE INFLUENCE OF SMOKING ON PLATELET BEHAVIOR, ENDOTHELIUM AND PLASMA-LIPIDS AND NORMALIZATION BY ASPIRIN [J].
BLACHE, D ;
BOUTHILLIER, D ;
DAVIGNON, J .
ATHEROSCLEROSIS, 1992, 93 (03) :179-188
[3]   A QUANTITATIVE ASSESSMENT OF PLASMA HOMOCYSTEINE AS A RISK FACTOR FOR VASCULAR-DISEASE - PROBABLE BENEFITS OF INCREASING FOLIC-ACID INTAKES [J].
BOUSHEY, CJ ;
BERESFORD, SAA ;
OMENN, GS ;
MOTULSKY, AG .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1995, 274 (13) :1049-1057
[4]   RELATIONSHIP BETWEEN DIET AND SMOKING - IS THE DIET OF SMOKERS DIFFERENT [J].
CADE, JE ;
MARGETTS, BM .
JOURNAL OF EPIDEMIOLOGY AND COMMUNITY HEALTH, 1991, 45 (04) :270-272
[5]   Passive smoking and impaired endothelium-dependent arterial dilatation in healthy young adults [J].
Celermajer, DS ;
Adams, MR ;
Clarkson, P ;
Robinson, J ;
McCredie, R ;
Donald, A ;
Deanfield, JE .
NEW ENGLAND JOURNAL OF MEDICINE, 1996, 334 (03) :150-154
[6]  
Ciruzzi M., 1996, European Heart Journal, V17, P309
[7]   CIGARETTE-SMOKING AND SERUM-LIPID AND LIPOPROTEIN CONCENTRATIONS - AN ANALYSIS OF PUBLISHED DATA [J].
CRAIG, WY ;
PALOMAKI, GE ;
HADDOW, JE .
BMJ-BRITISH MEDICAL JOURNAL, 1989, 298 (6676) :784-788
[8]   EFFECTS OF TOBACCO AND NON-TOBACCO CIGARETTE-SMOKING ON ENDOTHELIUM AND PLATELETS [J].
DAVIS, JW ;
SHELTON, L ;
EIGENBERG, DA ;
HIGNITE, CE ;
WATANABE, IS .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1985, 37 (05) :529-533
[9]   PASSIVE SMOKING AFFECTS ENDOTHELIUM AND PLATELETS [J].
DAVIS, JW ;
SHELTON, L ;
WATANABE, IS ;
ARNOLD, J .
ARCHIVES OF INTERNAL MEDICINE, 1989, 149 (02) :386-389
[10]  
DAVIS JW, 1982, CAN MED ASSOC J, V126, P637